{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:04:31Z","timestamp":1790255071603,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omton.2026.201299","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:39:55Z","timestamp":1784356795000},"page":"201299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-9861","authenticated-orcid":false,"given":"Benjamin","family":"Vesin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1389-1159","authenticated-orcid":false,"given":"Ingrid","family":"Fert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Ciret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00ebtitia","family":"Douguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-4715","authenticated-orcid":false,"given":"Fanny","family":"Moncoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-7461","authenticated-orcid":false,"given":"Amandine","family":"Noirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8293-3239","authenticated-orcid":false,"given":"Pierre","family":"Authi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Le Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Nemirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-4058","authenticated-orcid":false,"given":"Laleh","family":"Majlessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Charneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201299_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omton.2026.201299_bib2","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omton.2026.201299_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.euo.2018.10.010","article-title":"The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes","volume":"2","author":"Mazzone","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.omton.2026.201299_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/JU9.0000000000000137","article-title":"Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1","volume":"2","author":"Crawford","year":"2024","journal-title":"JU Open Plus"},{"key":"10.1016\/j.omton.2026.201299_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omton.2026.201299_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052569","article-title":"Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?","volume":"23","author":"von Amsberg","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2026.201299_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.canlet.2015.12.022","article-title":"Regulation of prostate cancer progression by the tumor microenvironment","volume":"380","author":"Shiao","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2026.201299_bib8","first-page":"197","article-title":"Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer","volume":"36","author":"Anassi","year":"2011","journal-title":"P T."},{"key":"10.1016\/j.omton.2026.201299_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201299_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2011.04.012","article-title":"Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer","volume":"69","author":"Thara","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.omton.2026.201299_bib11","article-title":"Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach","volume":"4","author":"Sridaran","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omton.2026.201299_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s42003-021-02251-6","article-title":"Lentiviral vector induces high-quality memory T cells via dendritic cells transduction","volume":"4","author":"Ku","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omton.2026.201299_bib13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/14760584.2021.1988854","article-title":"Use of lentiviral vectors in vaccination","volume":"20","author":"Ku","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omton.2026.201299_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030846","article-title":"Lentiviral Vectors as a Vaccine Platform against Infectious Diseases","volume":"15","author":"Nemirov","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omton.2026.201299_bib16","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1158\/1078-0432.CCR-19-1025","article-title":"First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1","volume":"25","author":"Somaiah","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201299_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202317723","article-title":"Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine","volume":"15","author":"Douguet","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omton.2026.201299_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41541-024-00894-0","article-title":"T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector","volume":"9","author":"Fert","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omton.2026.201299_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/14760584.2024.2374287","article-title":"Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers","volume":"23","author":"Demidova","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omton.2026.201299_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.canlet.2005.05.021","article-title":"Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues","volume":"236","author":"Cunha","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2026.201299_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5115\/acb.2012.45.3.149","article-title":"Prostate stem cell antigen gene is expressed in islets of pancreas","volume":"45","author":"Ono","year":"2012","journal-title":"Anat. Cell Biol."},{"key":"10.1016\/j.omton.2026.201299_bib22","first-page":"2546","article-title":"Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate","volume":"62","author":"Ross","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201299_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4062\/biomolther.2012.095","article-title":"Emerging roles of human prostatic Acid phosphatase","volume":"21","author":"Kong","year":"2013","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.omton.2026.201299_bib24","doi-asserted-by":"crossref","first-page":"40846","DOI":"10.1074\/jbc.M002755200","article-title":"Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells","volume":"275","author":"Yeung","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201299_bib25","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2002-09-2924","article-title":"Regulation of human beta 2-microglobulin transactivation in hematopoietic cells","volume":"101","author":"Gobin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201299_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2011.00048","article-title":"Expression regulation of major histocompatibility complex class I and class II encoding genes","volume":"2","author":"van den Elsen","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201299_bib27","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.ymthe.2022.04.016","article-title":"An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa","volume":"30","author":"Vesin","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201299_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/PL00007104","article-title":"Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines","volume":"19","author":"Grossmann","year":"2001","journal-title":"World J. Urol."},{"key":"10.1016\/j.omton.2026.201299_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/93.13.998","article-title":"Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses","volume":"93","author":"Griffith","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.omton.2026.201299_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0090-4295(99)80301-X","article-title":"Loss of HLA class I expression in prostate cancer: implications for immunotherapy","volume":"46","author":"Blades","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.omton.2026.201299_bib31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.juro.2007.03.109","article-title":"Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition","volume":"178","author":"Kitamura","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.omton.2026.201299_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201299_bib33","first-page":"2434","article-title":"Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure","volume":"35","author":"Corbett","year":"1975","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201299_bib34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.celrep.2017.10.024","article-title":"A Discrete Subset of Monocyte-Derived Cells among Typical Conventional Type 2 Dendritic Cells Can Efficiently Cross-Present","volume":"21","author":"Sheng","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201299_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1393598","article-title":"CCL3 augments tumor rejection and enhances CD8(+) T cell infiltration through NK and CD103(+) dendritic cell recruitment via IFNgamma","volume":"7","author":"Allen","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omton.2026.201299_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/IR:31:1:57","article-title":"Chemokines: control of primary and memory T-cell traffic","volume":"31","author":"Schaerli","year":"2005","journal-title":"Immunol. Res."},{"key":"10.1016\/j.omton.2026.201299_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cac2.12010","article-title":"CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target","volume":"40","author":"Zhang","year":"2020","journal-title":"Cancer Commun."},{"key":"10.1016\/j.omton.2026.201299_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq6509","article-title":"CXCL9 and CXCL10 bring the heat to tumors","volume":"7","author":"Reschke","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omton.2026.201299_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1335256","article-title":"Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness","volume":"14","author":"Hapuarachi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201299_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1254536","article-title":"T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses","volume":"346","author":"Schenkel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omton.2026.201299_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2568","article-title":"Sensing and alarm function of resident memory CD8(+) T cells","volume":"14","author":"Schenkel","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201299_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201299_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111142","article-title":"A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4(+) T cell immunity","volume":"40","author":"Lopez","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201299_bib44","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.celrep.2019.01.025","article-title":"Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8(+) T Cell Responses","volume":"26","author":"Cousin","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201299_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05134-6","article-title":"A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy","volume":"15","author":"Goloudina","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201299_bib46","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114459","article-title":"Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice","volume":"13","author":"Ku","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omton.2026.201299_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201299_bib48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.omton.2026.201299_bib49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7150\/jca.80803","article-title":"Current status and progress of the development of prostate cancer vaccines","volume":"14","author":"Wang","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.omton.2026.201299_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.641307","article-title":"Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer","volume":"12","author":"Sutherland","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201299_bib51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s42003-022-03843-6","article-title":"Reversible epigenetic alterations regulate class I HLA loss in prostate cancer","volume":"5","author":"Rodems","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omton.2026.201299_bib52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00262-009-0769-5","article-title":"Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer","volume":"59","author":"Seliger","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omton.2026.201299_bib53","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41467-023-37874-2","article-title":"Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy","volume":"14","author":"Bhatia","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201299_bib54","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3389\/fimmu.2018.02876","article-title":"Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1","volume":"9","author":"Colomer-Lluch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201299_bib55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/1742-4690-9-S2-P350","article-title":"Design and development of a new lentiviral based anti-HIV therapeutic vaccine","volume":"13","author":"Rodriguez","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.omton.2026.201299_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01969712","article-title":"Ubiquitin promoter-based vectors for high-level expression of selectable and\/or screenable marker genes in monocotyledonous plants","volume":"5","author":"Christensen","year":"1996","journal-title":"Transgenic Res."},{"key":"10.1016\/j.omton.2026.201299_bib57","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/j.1460-2075.1985.tb03693.x","article-title":"The human ubiquitin multigene family: some genes contain multiple directly repeated ubiquitin coding sequences","volume":"4","author":"Wiborg","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2026.201299_bib58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.chom.2020.12.010","article-title":"Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models","volume":"29","author":"Ku","year":"2021","journal-title":"Cell Host Microbe"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032992600175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032992600175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:32:56Z","timestamp":1790253176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295032992600175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S295032992600175X"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201299","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201299"}}